Janus Henderson Group PLC Has $509.98 Million Stake in Corteva, Inc. $CTVA

Janus Henderson Group PLC decreased its stake in shares of Corteva, Inc. (NYSE:CTVA) by 29.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 7,608,236 shares of the company’s stock after selling 3,132,619 shares during the period. Janus Henderson Group PLC’s holdings in Corteva were worth $509,983,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. JPL Wealth Management LLC acquired a new position in shares of Corteva during the 3rd quarter valued at about $25,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva during the 4th quarter valued at about $28,000. Redmont Wealth Advisors LLC acquired a new position in shares of Corteva during the 3rd quarter valued at about $29,000. Cornerstone Financial Management LLC acquired a new stake in Corteva in the 4th quarter valued at approximately $29,000. Finally, Basepoint Wealth LLC acquired a new stake in Corteva in the 4th quarter valued at approximately $30,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Corteva stock opened at $77.45 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company has a market capitalization of $51.80 billion, a PE ratio of 45.56, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The business has a 50 day simple moving average of $79.88 and a 200 day simple moving average of $75.59.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio (DPR) is 42.35%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. BNP Paribas Exane raised their target price on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Citigroup raised their target price on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Mizuho raised their target price on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Finally, CICC Research raised their target price on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.